What are the diagnostic criteria and treatment options for trigeminal neuralgia?

Trigeminal Neuralgia Diagnosis

Diagnostic Criteria

Trigeminal neuralgia is diagnosed based on sudden, unilateral, severe, brief stabbing recurrent episodes of pain in the distribution of one or more branches of the trigeminal nerve, triggered by innocuous stimuli. 1, 2

Key Clinical Features to Identify

• Pain character: Electric shock-like, abrupt in onset and termination, lasting seconds 1, 2
• Pain location: Limited to V1 (ophthalmic), V2 (maxillary), or V3 (mandibular) distribution 3
• Triggers: Brushing teeth, shaving, eating, cold exposure, heat, or light touch 4
• Unilateral presentation: Pain affects one side of the face 5, 1
• Paroxysmal nature: Recurrent attacks with pain-free intervals between episodes 6

Neurological Examination

• Classical TN: Neurological examination is typically normal 2
• Secondary TN: Examine for signs of multiple sclerosis or cerebellopontine angle tumors 2
• Look for sensory deficits in trigeminal distribution that would suggest secondary causes 7

Classification System

• Classical TN: Associated with neurovascular compression of the trigeminal nerve 8, 7
• Secondary TN: Associated with multiple sclerosis, tumors, or other neurological disorders 8, 2
• Type 2 TN: Presents with more prolonged pain between sharp shooting attacks, may have central origin 8

Essential Diagnostic Imaging

MRI with contrast of the trigeminal ganglion is mandatory prior to any interventional procedures. 2

• High-resolution MRI with 3D heavily T2-weighted sequences and MRA are essential for identifying neurovascular compression 9
• Pre- and post-contrast imaging provides optimal visualization of potential lesions 9
• Imaging congruence with surgical findings ranges from 83-100% 9
• MRI rules out secondary causes including multiple sclerosis and tumors 7, 6, 4

Critical Differential Diagnoses to Exclude

• Trigeminal autonomic cephalgias (SUNCT/SUNA): Look for autonomic features like tearing, eye redness, and rhinorrhea that are absent in TN 1
• Giant cell arteritis: In patients over 50 with temporal region pain, this requires urgent ESR/CRP and temporal artery biopsy to prevent blindness 8, 1
• Post-herpetic neuralgia: Presents with continuous burning pain rather than paroxysmal attacks 1
• Persistent idiopathic facial pain: Continuous non-anatomical pain without characteristic triggers 1

Common Diagnostic Pitfalls

• Failing to obtain MRI before labeling as classical TN can miss treatable secondary causes 7, 4
• Misdiagnosing trigeminal autonomic cephalgias as TN leads to inappropriate treatment selection 1
• Not considering giant cell arteritis in elderly patients with new-onset facial pain can result in permanent vision loss 8, 1
• Diagnosis relies almost entirely on patient history due to lack of objective diagnostic tests 2, 6

---

Treatment Algorithm for Trigeminal Neuralgia

First-Line Pharmacological Treatment

Start with carbamazepine 100 mg twice daily (200 mg/day), increasing by up to 200 mg/day at weekly intervals until pain control is achieved, not exceeding 1200 mg daily. 10

• Carbamazepine is FDA-approved specifically for trigeminal neuralgia and remains the gold standard 8, 10
• Initial pain relief occurs within 24 hours in one-third of eventual responders 8
• Over 40% achieve complete pain relief within one week 8
• More than 75% of responders do so within three months 8
• Maximal pain relief is typically achieved within one month 8

Alternative First-Line Option

• Oxcarbazepine is equally effective as carbamazepine but has a superior side effect profile, making it the preferred first-line option for many patients 8, 2
• Consider oxcarbazepine when carbamazepine side effects are intolerable 7, 3

Second-Line Pharmacological Options

When first-line treatment fails or is not tolerated:

• Lamotrigine as add-on or monotherapy 8, 1, 3
• Baclofen starting at 5 mg three times daily, rarely tolerating above 30-40 mg/day in elderly 8, 3
• Gabapentin combined with ropivacaine has shown efficacy in RCTs 8
• Pregabalin demonstrated efficacy in long-term cohort studies 8, 3

Special Considerations for Elderly Patients

• Start gabapentin at 100-200 mg/day, gradually increasing to 900-3600 mg/day in 2-3 divided doses 8
• Start pregabalin at 25-50 mg/day, increasing gradually to 150-600 mg/day in two divided doses 8
• Consider 5% lidocaine patch for localized pain due to low systemic absorption and excellent tolerability 8
• Lower starting doses and slower titration are essential in elderly patients 8

When to Consider Surgical Intervention

Surgical options should be considered when pain intensity increases despite medication optimization or when side effects from drug treatment become intolerable. 5, 8, 1

• Approximately 15% of patients fail to obtain at least 50% pain relief with carbamazepine 8
• Early neurosurgical consultation is recommended when initiating treatment to establish a comprehensive plan 8
• Patients may expect 100% pain relief, off all medications, for over five years after surgical treatment 5

Surgical Treatment Selection Algorithm

For Patients with Minimal Comorbidities and Neurovascular Compression

Microvascular decompression (MVD) is the technique of choice, offering 70% chance of being pain-free at 10 years. 8, 9, 2

• MVD is the only non-ablative surgical procedure 5, 8
• Provides superior long-term outcomes compared to ablative procedures 9, 2
• Initial success rates are 75-80% immediately after surgery 9
• Complete relief is initially achieved by three-quarters of patients, but half maintain this outcome at three years 5
• Complications include 2-4% risk of hearing loss and 0.4% mortality 8, 1

For Elderly Patients or Those with Major Comorbidities

Ablative procedures are preferred when MVD is contraindicated or patients are too frail for major neurosurgery. 1, 2, 7

Options include:

• Radiofrequency thermocoagulation: Recommended in elderly patients or those with major comorbidities 1, 2
• Glycerol rhizotomy 8, 1
• Balloon compression 8, 1
• Gamma Knife radiosurgery: Pain relief typically occurs within three months, with minimum dose of 70 Gy delivered to a 4 mm target 5

Disadvantages of Ablative Techniques

• Comparatively high rate of facial sensory loss 5
• Trigeminal motor dysfunction 5
• Higher pain recurrence rates compared to MVD 5, 9
• Sensory disturbance, including anaesthesia dolorosa, is the most frequent complication of stereotactic radiosurgery 5
• Only half of patients can permanently stop drug treatments after ablative procedures 5

Treatment Monitoring

• Attempt to reduce medication dose to minimum effective level every 3 months throughout treatment 10
• Monitor for side effects including drowsiness, dizziness, mental confusion, and dry mouth, particularly in elderly 8
• Dose adjustment necessary in patients with moderate or severe renal impairment 8
• Blood level monitoring increases efficacy and safety of anticonvulsants 10